Upstream Bio
Waltham, MA
Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma. They are clinical-stage monoclonal antibodies that inhibit the TSLP receptor, a validated target located upstream of various signaling cascades that influence a range of immune cells that are important in common and unusual illnesses.
upstreambio.comCompany Details
Founded
- 2021
Employees
- Between 50 - 100 employees
Raised
- $408,000,000
Headquarters Location
- Waltham, MA
Public
- Yes
Acquired
- No
CEO
Rand Sutherland
Founders
- Oren BeckerEran Perry
Company Collections
These are collections Upstream Bio is a part of. Click on the collection name to view similar companies.
Upstream Bio's Industries
Upstream Bio Headquarters Location
460 Totten Pond Road, Waltham, MA 02451
Total Amount Raised: $408,000,000
Upstream Bio Funding Rounds
IPO
Unknown
Series B
$200,000,000
Series B Investors
Enavate SciencesVenrock Healthcare Capital PartnersOmega Fund ManagementTCG Crossover ManagementOrbiMed AdvisorsAltshuler ShahamSamsara BioCapitalHBM Healthcare InvestmentsDecheng CapitalBain Capital Life SciencesWellington ManagementAccess IndustriesHBM PartnersSeries A
$8,000,000
Series A Investors
HBM PartnersSeries A
$200,000,000
Series A Investors
Maruho Co.OrbiMed AdvisorsSamsara BioCapitalDecheng CapitalTCG Crossover ManagementAltshuler ShahamAccess IndustriesOmega Fund ManagementHBM Healthcare Investments
Funding info provided by Diffbot.
Upstream Bio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Upstream Bio.